Oxbridge Re (NASDAQ:OXBR) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Oxbridge Re (NASDAQ:OXBR) released its quarterly earnings data on Thursday. The insurance provider reported $0.02 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.01), FiscalAI reports. Oxbridge Re had a return on equity of 2.22% and a net margin of 4.71%.The business had revenue of $0.94 million during the quarter, compared to the consensus estimate of $1.10 million.

Here are the key takeaways from Oxbridge Re’s conference call:

• Oxbridge returned to profitability, reporting second-quarter net income of $176,000, or $0.02 per share, versus a $1.87 million loss in the prior-year quarter. The improvement was driven by no underwriting losses, higher SurancePlus management-fee income, and lower professional fees and compensation.
• SurancePlus expanded beyond Oxbridge-originated reinsurance by closing five tokenized offerings, including three third-party opportunities from HCI Group and Fortex Re, raising $7.1 million in aggregate gross proceeds. Prior-year offerings exceeded their targeted annual returns, although the newer return targets assume no underwriting losses.
• Net premiums earned declined to $368,000 in the quarter and $924,000 for the first six months, versus $582,000 and $1.1 million, respectively, a result of lower weighted-average rates and less capital deployed into reinsurance contracts.
• Oxbridge launched AI GridWorks to develop, own, and operate 10- to 100-megawatt AI data centers, initially targeting the southeastern U.S. The company sees multiple monetization and financing options—including selling entitled, powered land, leasing data-center capacity, operating facilities, and eventually tokenizing interests—but the initiative remains in the development stage.
• Restricted cash and cash equivalents increased to $19.82 million as of June 30, 2026, from $6.98 million at year-end 2025, reflecting new tokenized-security investments, released collateral, and premium deposits.

Oxbridge Re Price Performance

NASDAQ:OXBR traded up $0.23 during trading hours on Friday, hitting $1.53. 206,609 shares of the stock traded hands, compared to its average volume of 72,278. The company has a market cap of $12.39 million, a price-to-earnings ratio of 76.54 and a beta of 1.94. Oxbridge Re has a 1 year low of $0.66 and a 1 year high of $2.86. The stock has a 50 day moving average price of $1.28 and a 200 day moving average price of $1.07. The company has a quick ratio of 8.15, a current ratio of 8.15 and a debt-to-equity ratio of 0.16.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on OXBR. Zacks Research raised shares of Oxbridge Re to a “hold” rating in a report on Wednesday, June 17th. Weiss Ratings upgraded shares of Oxbridge Re from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, July 28th. Finally, Maxim Group decreased their target price on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a research note on Tuesday, June 16th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $3.00.

Institutional Trading of Oxbridge Re

An institutional investor recently raised its position in Oxbridge Re stock. J.W. Cole Advisors Inc. lifted its position in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR) by 106.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 68,000 shares of the insurance provider’s stock after buying an additional 35,000 shares during the quarter. J.W. Cole Advisors Inc. owned approximately 0.89% of Oxbridge Re worth $90,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 5.64% of the company’s stock.

About Oxbridge Re

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.